Core Viewpoint - The company Feihe has launched a new generation of infant formula products under the strategy "New Generation More Suitable," focusing on comprehensive upgrades across the entire industry chain, breast milk-based formulas, fresh nutrition, and feeding effectiveness [2][10]. Group 1: Product Innovation - Feihe introduced the globally unique "Fresh Nutrition System," which emphasizes fresh milk sources, fresh ingredients, and fresh processing techniques to ensure the delivery of fresh nutrition [3]. - The company has established a "2-hour ecological circle" for rapid low-temperature transportation of fresh milk to factories, maximizing the retention of fresh nutrients [3]. - Feihe has achieved self-sufficiency in key raw materials for infant formula, ensuring traceability and quality control from milk source to production [5]. Group 2: Clinical Research and Development - Feihe has conducted clinical feeding studies since 2010, with the latest results showing that its "Star Flying" formula closely matches the growth and development outcomes of breastfed infants [8][10]. - The company has developed a "Chinese Mother Source Bionic Formula," closely aligning with the nutritional profile of Chinese breast milk, including a high proportion of Sn-2 DHA [10]. - Feihe's research efforts have led to three significant certifications, including being the first in China for breast milk research and infant formula patents [12]. Group 3: Market Leadership and Consumer Trust - Feihe has maintained the highest sales in the infant formula market in China for six consecutive years and globally for four years [10][12]. - The company has established the "Star Mom Club," a trusted platform for over 85 million Chinese mothers, providing scientific feeding guidance from pregnancy to age six [13]. - Feihe's initiatives, such as the "China Baby Day" and developmental self-assessment tools, aim to support parents in understanding their children's growth [13].

Core Viewpoint - The event highlighted the launch of "New Generation More Suitable" infant formula by Feihe, emphasizing its commitment to innovation and quality tailored for Chinese babies [1][3]. Group 1: Product Innovation - Feihe introduced the "Fresh Nutrition System," which focuses on fresh milk sources, raw materials, and processes to enhance the nutritional quality of its products [3][4]. - The company has developed a "Mother Source Bionic Formula" that closely mimics the nutritional profile of breast milk, including a significant upgrade in the Sn-2 DHA ratio to 52.5%, aligning closely with the average level found in breast milk [8]. Group 2: Research and Development - Feihe has been a pioneer in clinical feeding research for infants, with recent studies showing that its Star Flying Fan Zhuo Rui formula promotes infant growth and development similarly to breast milk [5][9]. - The company has participated in national research initiatives, including the "863 Program" and the "14th Five-Year Plan," to advance the understanding of Chinese breast milk [7][8]. Group 3: Industry Leadership - Feihe aims to lead the industry in establishing fresh nutrition standards and enhancing the overall quality of infant formula in China [3][4]. - The company emphasizes its responsibility as a leading brand to continue innovating and improving consumer services for the benefit of Chinese babies [8].

Core Viewpoint - The launch of "New Generation More Suitable" by Feihe Milk Powder emphasizes the company's commitment to developing products tailored to the physical needs of Chinese babies, showcasing significant advancements in research and product offerings [1][3]. Group 1: Product Innovation - Feihe has introduced a unique "Fresh Nutrition System," which focuses on fresh milk sources, raw materials, and production processes to enhance the nutritional quality of its products [5]. - The company has established a "2-hour ecological circle" for rapid low-temperature transportation of fresh milk to factories, ensuring the preservation of active nutrients [5]. - Feihe's new products, including Qicui and Jicui, aim to replicate the nutritional ecosystem of breast milk, enhancing the potential of infants [8]. Group 2: Research and Development - Feihe has been a pioneer in clinical feeding research for infants since 2010, with its flagship product, Xingfeifan, demonstrating growth and development outcomes comparable to breastfed infants [10]. - The company has developed a "Chinese Maternal Source Bionic Formula," closely aligning with the composition of Chinese breast milk, including a significant proportion of Sn-2 DHA [13]. - Feihe has received multiple authoritative certifications, including being the top brand in Chinese maternal source formula nutrition and infant formula patents [14]. Group 3: Market Position and Consumer Trust - Feihe has achieved the highest sales in the infant formula market in China for six consecutive years and globally for four years [14]. - The company has built a trusted platform, "Xingma Club," which provides scientific feeding guidance to over 85 million Chinese mothers [14]. - Feihe's commitment to addressing the needs of mothers has been recognized, with initiatives like "China Baby Day" and financial support for families [14][17].